![Michael K. Wilhelm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael K. Wilhelm
Directeur Général chez
IR BIOSCIENCES HOLDINGS, INC.
Profil
Michael K.
Wilhelm is the founder of Foresight Capital Corp.
He is currently the President & Chief Executive Officer of IR Biosciences Holdings, Inc. since 2015 and the President, Chief Executive Officer & Director of ImmuneRegen BioSciences, Inc. since 2011.
Postes actifs de Michael K. Wilhelm
| Sociétés | Poste | Début |
|---|---|---|
| IR BIOSCIENCES HOLDINGS, INC. | Directeur Général | 01/07/2003 |
ImmuneRegen BioSciences, Inc.
 ImmuneRegen BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops immunomodulator to improve pulmonary function and stimulating the human immune system | Directeur Général | 23/12/2004 |
Foresight Capital Corp.
 Foresight Capital Corp. Financial ConglomeratesFinance Provides private equity and debt funding services for institutional and private investors | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
IR Biosciences Holdings, Inc.
 IR Biosciences Holdings, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company | Health Technology |
ImmuneRegen BioSciences, Inc.
ImmuneRegen BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops immunomodulator to improve pulmonary function and stimulating the human immune system | Commercial Services |
Foresight Capital Corp.
Foresight Capital Corp. Financial ConglomeratesFinance Provides private equity and debt funding services for institutional and private investors | Finance |
Choisissez Zonebourse 
